Skip to main content

Table 1 Correlation between the number of negative lymph nodes removed and clinicopathologic factors

From: Number of negative lymph nodes is associated with disease-free survival in patients with breast cancer

Characteristic

 

Number of negative lymph nodes

Pvalue

  

0-10 (n = 607)

11-13 (n = 706)

14-16 (n = 554)

17-40 (n = 588)

 

Age

      

 <35

234

68 (11.2)

51 (7.2)

51 (9.2)

64 (10.9)

0.054

 ≥35

2221

539 (88.8)

655 (92.8)

503 (90.8)

524 (89.1)

 

Menopause

      

 Premenopause

1641

402 (66.2)

460 (65.2)

354 (63.9)

425 (72.3)

0.012*

 Postmenopause

814

205 (33.8)

246 (34.8)

200 (36.1)

163 (27.7)

 

pT stage

      

 T1

812

159 (26.2)

259 (36.7)

190 (34.3)

204 (34.7)

<0.001*

 T2

1428

352 (58.0)

398 (53.4)

323 (58.3)

355 (60.4)

 

 T3

155

71 (11.7)

41 (5.8)

25 (4.5)

18 (3.1)

 

 T4

60

25 (4.1)

8 (1.1)

16 (2.9)

11 (1.8)

 

pN stage

      

 N0

1263

120 (19.8)

430 (60.9)

342 (61.7)

371 (63.1)

<0.001*

 N1

769

185 (30.5)

220 (31.2)

174 (31.4)

190 (32.3)

 

 N2

207

115 (18.9)

44 (6.2)

30 (5.4)

18 (3.1)

 

 N3

216

187 (30.8)

12 (1.7)

8 (1.5)

9 (1.5)

 

ER

      

 Negative

953

245 (40.4)

252 (35.7)

219 (39.5)

237 (40.3)

0.304

 Positive

1292

321 (52.9)

384 (54.3)

287 (51.8)

300 (51.0)

 

 Unknown

210

41 (6.7)

70 (10.0)

48 (8.7)

51 (8.7)

 

PR

      

 Negative

824

207 (34.1)

223 (31.5)

198 (35.7)

196 (33.3)

0.398

 Positive

1421

359 (59.1)

413 (58.5)

308 (55.6)

341 (58.0)

 

 Unknown

210

41 (6.8)

70 (10.0)

48 (8.7)

51 (8.7)

 

Her-2

      

 Negative

1377

329 (54.2)

395 (56.0)

307 (55.4)

346 (58.8)

0.460

 Positive

666

168 (27.7)

183 (25.9)

157 (28.3)

158 (26.9)

 

 Unknown

412

110 (18.1)

128 (18.1)

90 (16.3)

84 (14.3)

 
  1. Data are presented as number (percentage).
  2. ER, estrogen receptor; PR, progesterone receptor; Her-2, human epidermal growth factor receptor-2.
  3. *P < 0.05 indicates a significant difference.